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This case demonstrates the importance of consid-
ering curable causes of ventilatory failure despite
its common occurrence in patients with chronic
obstructive pulmonary disease (COPD).
Introduction
COPD is a common disease that places a consider-
able burden on society; estimates based on disabil-
ity life-years (DALY) suggests that COPD will
become the ﬁfth leading cause of disability world-
wide by 2020.
1 The term ‘exacerbation of COPD’
describes an acute deterioration in the patient’s
baseline symptoms (notably dyspnoea, cough or
sputum production) and a necessity to change
their usual medications.
2 ‘Exacerbations’ with
accompanying ventilatory failure in patients
with severe COPD are a frequent cause of admis-
sion to hospital. We report an individual admitted
in ventilatory failure who was initially diagnosed
as having an exacerbation of COPD, but examin-
ation and investigations in clinic revealed that a
tonsillar cyst was causing obstructive sleep
apnoea, which upon removal led to substantial
improvements.
Case report
A 64-year-old woman was referred to the COPD
clinic. She had a 22-pack–year smoking history
and had recently presented as an emergency with
drowsiness. Shewasfound tohavea signiﬁcant ven-
tilatory failure causing respiratory acidosis (FiO2 0.4
pH 7.206 (normal range 7.35–7.45), paCO2 12.18kPa
(4.67–6kPa), paO2 16.69kPa (9.3–14kPa), HCO3
35.4mmol/L (21–32mmol/L), base excess (BE)
3.8 mmol/L( +/–2 . 5 m m o l /L). She required inten-
sive care with bi-level positive pressure ventilatory
support, nebulized bronchodilators, corticosteroids
a n da n t i b i o t i c s .P r i o rt od i s c h a r g e ,h e ra r t e r i a l
blood gas showed pH 7.416, paCO2 6.68kPa, paO2
7.89kPa, HCO3 31.5mmol/L, BE 5.6 mmol/Lb r e a t h -
ing air. The working diagnosis from the admitting
team was acute-on-chronic ventilatory failure due
to pneumonia and COPD. On review in clinic it
was noted that her CTPA during admission
revealed only moderate upper-lobe centrilobular
emphysema and no pulmonary emboli, with only
minor consolidation in the lingula.
Pulmonary function tests demonstrated an
obstructive pattern: FEV1 0.84l (33.8% of pre-
dicted), FVC 2.2l (75.2%), VC 2.34l (76.3%),
FEV1/VC 35.77% (46.5%), KCO 1.19mmol/min/
kPa/L (80.4%), TLCO 4.82mmol/min/kPa
(61.0%) compatible with COPD. On detailed ques-
tioning in clinic, she had never had any signiﬁcant
problems with breathlessness or exacerbations but
felt she lacked energy. It was felt that her chronic
ventilatory failure may not be solely due to her
COPD and on further examination of her orophar-
ynx there was an enlarged left tonsil. Her body
mass index was 30.4 kg/m
2. She underwent noc-
turnal oximetry which showed evidence of signiﬁ-
cant nocturnal hypoventilation and a desaturation
index of 41.7 per hour (Figures 1a and 1b). She had
a hypoxic challenge test as she wished to under-
take an aircraft ﬂight but this was terminated at
9 minutes due to oxygen desaturation to 82%
while breathing FiO2 0.15 and her arterial blood
gas post-test showed a pH 7.365, paCO2 6.18kPa
and paO2 5.68kPa. It was felt that she had obstruc-
tive sleep apnoea and ventilatory failure due to the
enlarged tonsil with a lesser contribution from her
COPD. She underwent urgent tonsillectomy
which revealed benign lymphoid hyperplasia
on histology. Postoperatively, her symptoms
improved dramatically; her Epworth score fell
from 22 preoperatively to 0. She and her
husband reported a signiﬁcant improvement in
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1her mood and energy, reﬂected in a marked
improvement in her desaturation index to 11.9
per hour (Figures 1c and 1d), and arterial blood
gases improved to paO2 10.28, paCO2 4.85kPa
and pH 7.412. Furthermore, she was able to com-
plete her hypoxic challenge test with improved
post-test arterial blood gases of pH 7.464, paO2
8.3kPa, paCO2 4kPa, HCO3 20.9mmol/L, BE
–1.7 mmol/L. Pulmonary function tests showed
little change six months postoperatively; FEV1
0.88l (35.9% of predicted), FVC 1.14l (73.6%),
indicating that her clinical improvement was not
due to recovery in her lung function.
Discussion
There are many contributing factorsto chronic ven-
tilatoryfailureinCOPDsuchasairﬂowobstruction,
reduced gas exchange, respiratory muscle weak-
ness and obesity hypoventilation.
3 Our patient
with a history of COPD, presented with
Figure 1
(a) Overnight pulse oximetry measured prior to tonsillectomy. Saturations are the top trace and pulse rate
is the bottom trace. A desaturation event was characterized as a drop in saturations by at least 4% for a
minimum duration of 10 s. A pulse event was a change in rate by at least 6 bpm for a minimum of
8 s. Adjusted index SpO2 41.7, minimum SpO2 57, average SpO2 83.7, average pulse rate 84.7, low pulse
rate 58, Epworth Score 22; (b) Measured oxygen desaturation prior to tonsillectomy between 02:00 and
05:00; (c) Overnight pulse oximetry measured 6 months post-tonsillectomy. Saturations are the top trace
and pulse rate is the bottom trace. A desaturation event was characterized as a drop in saturations by at
least 4% for a minimum duration of 10 s. A pulse event was a change in rate by at least 6 bpm for a
minimum of 8 s. Adjusted index SpO2 11.9, minimum SpO2 76, average SpO2 87.8, average pulse rate
74.9, low pulse rate 45, Epworth Score 0; (d) Measured oxygen desaturation 6 months post-tonsillectomy
between 01:00 and 03:00
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2acute-on-chronic ventilatory failure with decom-
pensation due to a mild pneumonia. On review in
a specialist COPD clinic, it was thought she had
chronic ventilatory failure but her COPD did not
sufﬁciently account for this. Detailed examination
suggested that a tonsillar cyst was causing obstruc-
tive sleep apnoea and hypoventilation, which on
removal led to resolution of symptoms and
abnormalities in overnight oximetry, arterial blood
gas and response to hypoxic challenge.
As a patient with COPD, being admitted to
hospital led to an initial treatment of having
an ‘exacerbation’ of her disease without further
investigation of possible precipitants. Viral and
bacterial pathogens, such as rhinoviruses and hae-
mophilus inﬂuenzae, respectively, are common,
and pollutants such as ozone, sulphur and
nitrous oxide may also trigger exacerbations.
4
Basic clinical history, examination and investi-
gations will help with separating infectious
exacerbations with differential diagnoses which
are varied, and commonly include pneumonia,
pneumothorax, pulmonary embolus and cardiac
failure.
5 The arterial blood gas can be helpful in
identifying patients with chronic ventilatory
failure by the presence of a disproportionately
raised bicarbonate level and raised arterial
carbon dioxide level compared to a relatively
normal pH. Common causesof chronic ventilatory
failure are listed in Table 1.
Obstructive sleep apnoea is a clinical syndrome
that describes the presence of episodes of apnoea
and hypopnea with symptoms of daytime somno-
lence. The prevalence of this condition is estimated
to be at about 4% of men and 2% of women in a
cohortstudyof402middle-agedadults.
6Co-existing
COPD and obstructive sleep apnoea is known as
overlap syndrome and is present in 1% of patients
over the age of 40 years.
7 The aetiology of this is
poorly understood. In adults, a range of surgical
approaches, including tonsillectomy, uvulopalatal
pharyngoplasty and tracheostomy in very severe
cases have been advocated, but the role of surgery
in the management of obstructive sleep apnoea
remains uncertain.
8Long-term treatment with dom-
iciliary continuous positiveairwaypressureremains
the mainstay of management because of its ben-
eﬁcial effects on daytime symptoms.
9
Conclusion
This case reminds us of the importance of asses-
sing for causes of exacerbations and reversible
causes of chronic ventilatory failure even in appar-
ently common clinical scenarios, as identiﬁcation
of them can lead to a cure.
• Exacerbations of COPD are deﬁned as an
acute and sustained deterioration in a patient’s
symptoms that are beyond the normal
day-to-day variability and have many possible
causes.
• Chronic ventilatory failure is associated with a
raised arterial carbon dioxide and bicarbonate
with a relatively mild acidaemia.
• Causes of chronic ventilatory failure include
COPD, bronchiectasis and extra-pulmonary
conditions such as neuromuscular disorders.
• Long-term treatment with domiciliary continu-
ous positive pressure airway support is the
mainstay of management of patients with
obstructive sleep apnoea.
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Table 1
Common causes of chronic ventilatory failure
Category Examples
Pulmonary COPD
Bronchiectasis
Cystic ﬁbrosis
Chest wall restriction Obesity hypoventilation
Scoliosis
Thoracoplasty
Neuromuscular
disease
Motor neurone disease
Myotonic dystrophy
Muscular dystrophy
Neurological disease Spinal cord trauma
Central hypoventilation
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